CYP19A1 and breast cancer: Several studies have demonstrated that calcitriol or EB1089 can also suppress aromatase expression and activity, resulting in the reduction of estrogen synthesis in different ER-positive BC cell lines (MCF-7, ZR-75-1, and T-47D) [150,151,152,153,154].